Literature DB >> 19185590

The polo-like kinase 1 regulates CDC25B-dependent mitosis entry.

Valerie Lobjois1, Denis Jullien, Jean-Pierre Bouché, Bernard Ducommun.   

Abstract

Activation of cyclin-dependent kinase complexes (CDK) at key cell cycle transitions is dependent on their dephosphorylation by CDC25 dual-specificity phosphatases (CDC25A, B and C in human). The CDC25B phosphatase plays an essential role in controlling the activity of CDK1-cyclin B complexes at the entry into mitosis and together with polo-like kinase 1 (PLK1) in regulating the resumption of cell cycle progression after DNA damage-dependent checkpoint arrest in G2. In this study, we analysed the regulation of CDC25B-dependent mitosis entry by PLK1. We demonstrate that PLK1 activity is essential for the relocation of CDC25B from the cytoplasm to the nucleus. By gain and loss of function analyses, we show that PLK1 stimulates CDC25B-induced mitotic entry in both normal conditions and after DNA-damage induced G2/M arrest. Our results support a model in which the relocalisation of CDC25B to the nucleus at the G2-M transition by PLK1 regulates its mitotic inducing activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19185590     DOI: 10.1016/j.bbamcr.2008.12.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

Review 1.  Prophase I arrest and progression to metaphase I in mouse oocytes: comparison of resumption of meiosis and recovery from G2-arrest in somatic cells.

Authors:  Petr Solc; Richard M Schultz; Jan Motlik
Journal:  Mol Hum Reprod       Date:  2010-05-07       Impact factor: 4.025

2.  Female infertility in PDE3A(-/-) mice: polo-like kinase 1 (Plk1) may be a target of protein kinase A (PKA) and involved in meiotic arrest of oocytes from PDE3A(-/-) mice.

Authors:  Weixing Shen; Faiyaz Ahmad; Steven Hockman; John Ma; Hitoshi Omi; Nalini Raghavachari; Vincent Manganiello
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

3.  Topokaryotyping demonstrates single cell variability and stress dependent variations in nuclear envelope associated domains.

Authors:  Anamarija Jurisic; Chloé Robin; Pavel Tarlykov; Lee Siggens; Brigitte Schoell; Anna Jauch; Karl Ekwall; Claus Storgaard Sørensen; Marc Lipinski; Muhammad Shoaib; Vasily Ogryzko
Journal:  Nucleic Acids Res       Date:  2018-12-14       Impact factor: 16.971

4.  Phospho-Bcl-x(L)(Ser62) plays a key role at DNA damage-induced G(2) checkpoint.

Authors:  Jianfang Wang; Myriam Beauchemin; Richard Bertrand
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

5.  Inhibitory phosphorylation of cyclin-dependent kinase 1 as a compensatory mechanism for mitosis exit.

Authors:  Jeremy P H Chow; Randy Y C Poon; Hoi Tang Ma
Journal:  Mol Cell Biol       Date:  2011-01-24       Impact factor: 4.272

6.  Ser149 is another potential PKA phosphorylation target of Cdc25B in G2/M transition of fertilized mouse eggs.

Authors:  Jianying Xiao; Chao Liu; Junjie Hou; Cheng Cui; Didi Wu; Huiyu Fan; Xiaohan Sun; Jun Meng; Fuquan Yang; Enhua Wang; Bingzhi Yu
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

7.  Distinct pools of cdc25C are phosphorylated on specific TP sites and differentially localized in human mitotic cells.

Authors:  Celine Franckhauser; Daria Mamaeva; Lisa Heron-Milhavet; Anne Fernandez; Ned J C Lamb
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

Review 8.  Positive-feedback loops in cell cycle progression.

Authors:  Joseph R Pomerening
Journal:  FEBS Lett       Date:  2009-10-07       Impact factor: 4.124

Review 9.  Feedback loops and reciprocal regulation: recurring motifs in the systems biology of the cell cycle.

Authors:  James E Ferrell
Journal:  Curr Opin Cell Biol       Date:  2013-08-05       Impact factor: 8.382

Review 10.  Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies.

Authors:  Swastika Sur; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2016-04-02       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.